Another use of oxycontin: The case for enhancing liability for off-label drug marketing

被引：0
|
作者：
Ford, MA [1 ]
机构：
[1] Boston Univ, Boston, MA 02215 USA
来源：
BOSTON UNIVERSITY LAW REVIEW | 2003年 / 83卷 / 02期
关键词：
D O I：
暂无
中图分类号：
D9 [法律]; DF [法律];
学科分类号：
0301 ;
摘要：
引用
收藏
页码：429 / 464
页数：36
相关论文
共 50 条
  • [1] Free Speech, Drug Marketing, and Off-Label Use
    Vivian, Jesse C.
    [J]. US PHARMACIST, 2011, 36 (12) : 46 - 48
  • [2] Aggravated liability in off-label use
    Broglie, Max
    [J]. AKTUELLE UROLOGIE, 2006, 37 (06) : 417 - 419
  • [3] Off-Label Use vs Off-Label Marketing Part 2: Off-Label Marketing- Consequences for Patients, Clinicians, and Researchers
    Van Norman, Gail A.
    [J]. JACC-BASIC TO TRANSLATIONAL SCIENCE, 2023, 8 (03): : 359 - 370
  • [4] Off-Label Drug Use and Promotion
    Gianutsos, Gerald
    [J]. US PHARMACIST, 2014, 39 (10) : 55 - 64
  • [5] Off-label drug use in hospitals
    Danes, Imma
    Alerany, Carmen
    Ferrer, Anna
    Vallano, Antoni
    [J]. MEDICINA CLINICA, 2014, 143 (07): : 327 - 328
  • [6] Appropriate off-label drug use
    Lee, Sang Moo
    [J]. JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2018, 61 (03): : 140 - 146
  • [7] Off-Label Drug Use in Children
    Jain, Surabhi S.
    Bavdekar, S. B.
    Gogtay, Nithya J.
    Sadawarte, Pranjali A.
    [J]. INDIAN JOURNAL OF PEDIATRICS, 2008, 75 (11): : 1133 - 1136
  • [8] Off-label drug use in children
    Jain S.S.
    Bavdekar S.B.
    Gogtay N.J.
    Sadawarte P.A.
    [J]. The Indian Journal of Pediatrics, 2008, 75 (11) : 1133 - 1136
  • [9] Corporate Malfeasance, Off-Label Use, and Surgeon Liability
    Bal, B. Sonny
    Brenner, Lawrence H.
    [J]. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2013, 471 (01) : 4 - 8
  • [10] Off-Label Use vs Off-Label Marketing of Drugs Part 1: Off-Label Use-Patient Harms and Prescriber Responsibilities
    Van Norman, Gail A.
    [J]. JACC-BASIC TO TRANSLATIONAL SCIENCE, 2023, 8 (02): : 224 - 233
12345